• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    P

    Pain Management Institute

    196论文总数
    2,852引用总数

    论文量&引用量时间轴

    机构学者

    论文(196)

    年份
    起
    –
    止
    排序
    1Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs
    Abigail Elliott, Sanny Juresic, Leslie Siegel, Nathan T. Smith

    Objectives: The primary objective of this article was to examine literature from the last 10 years surrounding cardiovascular risks associated with NSAID use. Methods: A systematic search was developed to include randomized control trials and systematic review meta-analyses that focused on the cardiovascular effects associated with NSAID use. Results: The search and screen identified 10 articles published in the last 10 years to be included in the review. Discussion: The most common cardiovascular risks studied in the included literature were hemodynamic effects and myocardial infarction. The evidence in the included studies suggests that concerns of adverse hemodynamic effects may be overstated with short-term NSAID use. Myocardial infarction was shown to be a very serious, but rare, side effect associated with NSAID use. Practitioners should weigh this risk when using NSAIDs in patients with an increased risk of MI at baseline. Other included studies described risks of Kounis syndrome, QTc prolongation, and potential reversal of right ventricular dysfunction in patients using NSAIDs.

    2026CLINICAL JOURNAL OF PAIN(2026)
    引用
    AI阅读
    加入学术空间
    2Things Pain Takes
    Erin Sanzone, Leena Mathew
    2026Regional Anesthesia & Pain Medicine(2026)
    引用
    AI阅读
    加入学术空间
    3Cancer-Related Neuropathic Pain: A Review of Contemporary Diagnostic and Therapeutic Approaches
    Ozana Katarina Tot, Leyla Sallabi Bukvić,Anja Petričević, Dijana Hnatešen, Dino Budrovac,Ana Cicvarić

    Aim: The aim of this review article is to summarize current knowledge on the etiology, pathophysiology, diagnosis, clinical characteristics, and treatment options for cancer-related neuropathic pain (CRNP), with an emphasis on recent advances in pharmacological and non-pharmacological management strategies. Methods: A narrative review of contemporary literature and clinical recommendations on cancer-related neuropathic pain was conducted. Relevant evidence addressing the etiology, pathophysiology, diagnosis, clinical characteristics, and pharmacological and non-pharmacological management of CRNP was examined. Particular attention was given to diagnostic criteria recommended by the International Association for the Study of Pain (IASP), validated assessment tools such as the DN4 questionnaire, neuroimmune mechanisms underlying neuropathic pain, and contemporary therapeutic approaches. Results: The reviewed evidence indicates that cancer-related neuropathic pain is a complex, multifactorial condition associated with tumor invasion, nerve compression, chemotherapy- and radiotherapy-induced nerve injury, neuroinflammation, and central sensitization. Diagnosis relies on recognizing characteristic sensory symptoms and demonstrating nervous system involvement, with validated tools such as the DN4 questionnaire supporting clinical assessment. Current evidence supports multimodal pharmacological management, including opioids combined with adjuvant agents such as gabapentinoids, tricyclic antidepressants, and serotonin-norepinephrine reuptake inhibitors. Emerging approaches, including monoclonal antibodies, cannabinoids, intrathecal analgesics, and targeted molecular therapies, show promising but still limited evidence. Non-pharmacological interventions, including acupuncture, cognitive-behavioral therapies Conclusion: Cancer-related neuropathic pain remains underrecognized and difficult to treat, significantly impairing patients’ quality of life and treatment outcomes. Early diagnosis, individualized multimodal therapy, and integration of pharmacological and supportive interventions are essential for effective management. Future advances in molecular biology, immunology, and pharmacogenomics may enable more targeted and personalized therapeutic strategies for patients with cancer-related neuropathic pain.

    2026Southeastern European Medical Journal(2026)
    引用
    AI阅读
    加入学术空间
    4Multicenter, Randomized, Placebo-Controlled Crossover Trial Evaluating Topical Lidocaine for Mechanical Cervical Pain
    Steven P. Cohen,Thomas M. Larkin, Aidan S. Weitzner,Edward Dolomisiewicz,Eric J. Wang,Annie Hsu,Mirinda Anderson-White, Marin S. Smith,Zirong Zhao

    Background There are few efficacious treatments for mechanical neck pain, with controlled trials suggesting efficacy for muscle relaxants and topical nonsteroidal anti-inflammatory drugs. Although studies evaluating topical lidocaine for back pain have been disappointing, the more superficial location of the cervical musculature suggests a possible role for topical local anesthetics. Methods This study was a randomized, double-blind, placebo-controlled crossover trial performed at four U.S. military, Veterans Administration, academic, and private practice sites, in which 76 patients were randomized to receive either placebo followed by lidocaine patch for 4-week intervals (group 1) or a lidocaine-then-placebo patch sequence. The primary outcome measure was mean reduction in average neck pain, with a positive categorical outcome designated as a reduction of at least 2 points in average neck pain coupled with at least a 5-point score of 7 points on the Patient Global Impression of Change scale at the 4-week endpoint. Results For the primary outcome, the median reduction in average neck pain score was −1.0 (interquartile range, −2.0, 0.0) for the lidocaine phase versus −0.5 (interquartile range, −2.0, 0.0) for placebo treatment (P = 0.17). During lidocaine treatment, 27.7% of patients experienced a positive outcome versus 14.9% during the placebo phase (P = 0.073). There were no significant differences between treatments for secondary outcomes, although a carryover effect on pain pressure threshold was observed for the lidocaine phase (P = 0.015). A total of 27.5% of patients in the lidocaine group and 20.5% in the placebo group experienced minor reactions, the most common of which was pruritis (P = 0.36). Conclusions The differences favoring lidocaine were small and nonsignificant, but the trend toward superiority of lidocaine suggests more aggressive phenotyping and applying formulations with greater penetrance may provide clinically meaningful benefit. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New

    2024ANESTHESIOLOGY(2024)引用:1
    引用
    AI阅读
    加入学术空间
    5Intra-articular Glucose Injections for Orthoregeneration of Frozen Shoulder. A Clinical Case.
    Jan Kersschot

    Frozen shoulder or adhesive capsulitis is a difficult to treat disorder characterized by pain and loss of movement. Novel therapies such as hydraulic distension with orthobiologics may improve outcomes among individuals with this debilitating condition. The clinical case in this article describes the treatment of a patient with frozen shoulder using a series of joint injections using high volumes of sugar water. The positive outcome of this novel injection technique is an invitation to design clinical trials using orthobiologics for frozen shoulder.

    2023Medical Research Archives(2023)引用:4
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 196 篇论文

    合作机构(100)

    哥本哈根大学合作论文 8
    悉尼大学合作论文 7
    Boston Fusion (United States)合作论文 5
    德克萨斯大学奥斯汀分校合作论文 4
    犹他大学合作论文 4
    Biomechanics Institute of Valencia合作论文 3
    Carolinas Pain Institute合作论文 3
    沃尔特里德陆军医疗中心合作论文 3
    Orthopaedic Research合作论文 3
    Medical Advanced Pain Specialists合作论文 3

    机构统计